Syndromic microphthalmia-anophthalmia-coloboma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:202948
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Syndromic microphthalmia-anophthalmia-coloboma (MAC) refers to a group of rare developmental eye disorders in which abnormally small eyes (microphthalmia), absent eyes (anophthalmia), or gaps in ocular structures (coloboma) occur alongside additional systemic abnormalities affecting other organ systems. Unlike isolated MAC, the syndromic forms are characterized by the presence of extra-ocular features, which may include intellectual disability, craniofacial anomalies, cardiac defects, skeletal malformations, brain abnormalities, renal anomalies, and genital malformations, depending on the specific underlying genetic cause. The eye findings result from disrupted development during early embryogenesis, when the optic vesicle and optic fissure fail to form or close properly. The severity of visual impairment ranges from mild visual reduction in cases of small colobomas to complete blindness in bilateral anophthalmia. Numerous genetic causes have been identified for syndromic MAC, including mutations in genes such as SOX2, OTX2, PAX6, FOXE3, BMP4, GDF6, STRA6, ALDH1A3, RAX, VSX2, and others. The inheritance pattern varies depending on the specific syndrome and causative gene, encompassing autosomal dominant, autosomal recessive, and X-linked patterns. Chromosomal abnormalities and copy number variants can also be responsible. Genetic testing, including chromosomal microarray and gene panel or exome sequencing, is recommended for diagnosis and genetic counseling. There is currently no cure for syndromic MAC. Management is multidisciplinary and supportive, involving ophthalmologists, geneticists, and specialists relevant to the associated systemic features. Ocular management may include conformers or prosthetic eyes to promote orbital growth in anophthalmia or severe microphthalmia, surgical correction of coloboma-related complications such as retinal detachment, and low-vision rehabilitation. Associated anomalies such as cardiac defects or renal malformations require appropriate specialist care. Early intervention programs and developmental support are important for children with associated intellectual disability.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Syndromic microphthalmia-anophthalmia-coloboma.

View clinical trials →

No actively recruiting trials found for Syndromic microphthalmia-anophthalmia-coloboma at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Syndromic microphthalmia-anophthalmia-coloboma community →

No specialists are currently listed for Syndromic microphthalmia-anophthalmia-coloboma.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Syndromic microphthalmia-anophthalmia-coloboma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Syndromic microphthalmia-anophthalmia-colobomaForum →

No community posts yet. Be the first to share your experience with Syndromic microphthalmia-anophthalmia-coloboma.

Start the conversation →

Latest news about Syndromic microphthalmia-anophthalmia-coloboma

No recent news articles for Syndromic microphthalmia-anophthalmia-coloboma.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Syndromic microphthalmia-anophthalmia-coloboma

What is Syndromic microphthalmia-anophthalmia-coloboma?

Syndromic microphthalmia-anophthalmia-coloboma (MAC) refers to a group of rare developmental eye disorders in which abnormally small eyes (microphthalmia), absent eyes (anophthalmia), or gaps in ocular structures (coloboma) occur alongside additional systemic abnormalities affecting other organ systems. Unlike isolated MAC, the syndromic forms are characterized by the presence of extra-ocular features, which may include intellectual disability, craniofacial anomalies, cardiac defects, skeletal malformations, brain abnormalities, renal anomalies, and genital malformations, depending on the spec

At what age does Syndromic microphthalmia-anophthalmia-coloboma typically begin?

Typical onset of Syndromic microphthalmia-anophthalmia-coloboma is neonatal. Age of onset can vary across affected individuals.